Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis-Reference-Cited by-同舟云学术

Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis

Published:2019-08-16 Issue:1 Volume:19 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Moodley R.,Suleman F.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-019-4403-8.pdf

Reference32 articles.

1. Nguyen TA, Knight R, Roughead EE, Brooks G, Mant A. Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries. Health Policy Plan. 2015;30:267–80.

2. Lu Y, Hernandez P, Abegunde D, Edejer T. The world medicines situation 2011 - medicine expenditures. 2011.

3. World Health Organization. Who Guideline on Country Pharmaceutical Pricing Policies 2015;:134. http://apps.who.int/iris/bitstream/10665/153920/1/9789241549035_eng.pdf .

4. Moreno-Torres I, Puig-Junoy J, Raya JM. The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain. Eur J Health Econ. 2011;12:563–73.

5. Sood N, De Vries H, Gutierrez I, Lakdawalla DN, Goldman DP. The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff. 2009:28.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China;Frontiers in Pharmacology;2024-08-20

2. Cost and availability of selected medicines after implementation of increased import verification fees;BMC Health Services Research;2024-01-04

3. A desktop review of evaluation of implementation of national medicines policies in SADC countries;Heliyon;2023-11

4. Equity in Access to and Quality Use of Medicines in Low- and Middle-Income Countries;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023

5. Equity in Access to and Quality Use of Medicines in Low- and Middle-Income Countries;Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy;2023